These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 25792109

  • 1. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
    Magné J, Huneau JF, Borderie D, Mathé V, Bos C, Mariotti F.
    Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
    [Abstract] [Full Text] [Related]

  • 2. ADMA and hyperhomocysteinemia.
    Dayal S, Lentz SR.
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [Abstract] [Full Text] [Related]

  • 3. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH.
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S, McDowell I, Goodfellow J, Stabler S, Boger R, Allen R, Newcombe R, Lewis M, Moat S.
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG.
    Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
    [Abstract] [Full Text] [Related]

  • 13. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.
    Rodionov RN, Dayoub H, Lynch CM, Wilson KM, Stevens JW, Murry DJ, Kimoto M, Arning E, Bottiglieri T, Cooke JP, Baumbach GL, Faraci FM, Lentz SR.
    Circ Res; 2010 Feb 19; 106(3):551-8. PubMed ID: 20019334
    [Abstract] [Full Text] [Related]

  • 15. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H, Puustjärvi T, Kontkanen M, Valtonen P, Teräsvirta M, Uusitalo H.
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb 19; 245(2):204-9. PubMed ID: 17024436
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF.
    Med Hypotheses; 2004 Feb 19; 63(4):699-708. PubMed ID: 15325021
    [Abstract] [Full Text] [Related]

  • 17. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP.
    Circulation; 2003 Aug 26; 108(8):933-8. PubMed ID: 12912818
    [Abstract] [Full Text] [Related]

  • 18. Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines.
    Antoniades C, Tousoulis D, Marinou K, Vasiliadou C, Tentolouris C, Bouras G, Pitsavos C, Stefanadis C.
    Am J Clin Nutr; 2006 Oct 26; 84(4):781-8. PubMed ID: 17023704
    [Abstract] [Full Text] [Related]

  • 19. Methionine-induced homocysteinemia impairs endothelial function in hypertensives: the role of asymmetrical dimethylarginine and antioxidant vitamins.
    Tousoulis D, Bouras G, Antoniades C, Marinou K, Papageorgiou N, Miliou A, Hatzis G, Stefanadi E, Tsioufis C, Stefanadis C.
    Am J Hypertens; 2011 Aug 26; 24(8):936-42. PubMed ID: 21490695
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
    Stühlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP.
    Circulation; 2001 Nov 20; 104(21):2569-75. PubMed ID: 11714652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.